Skip to content

4/AAccepted May 13, 6:11 PM ET

Nolet Chris 4/A

RVNCRevance Therapeutics, Inc.

Accepted (ET)

6:11 PM

May 13, 2022

Filed

May 13, 2022

Documents

1

Size

5.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.